Consensus EPS · Q1 2027
$1.39
Consensus revenue · Q1 2027
$9.5B
Analysts
16
Expected report
Sep 1, 2026
What to watch
- Analyst ratings: Mixed
Analyst consensus
Based on estimates from 16 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $9.5B | $9.5B | $9.6B |
| EPS | $1.37 | $1.39 | $1.39 |
| EBITDA | $2.5B | $2.6B | $2.6B |
| EBIT | $1.7B | $1.8B | $1.8B |
| Net income | $1.7B | $1.8B | $1.8B |
- Revenue$9.5B
- EPS$1.39
- EBITDA$2.6B
- EBIT$1.8B
- Net income$1.8B
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q4 2026 | $9.8B | $9.6B | +1.9% | $1.55 | $1.54 | +0.6% |
- Q4 2026+1.9%+0.6%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
| Metric | Now | 30d ago | 60d ago | 90d ago | 30d Δ |
|---|---|---|---|---|---|
| Revenue | $9.6B | $9.6B | — | — | 0% |
| EPS | $1.43 | $1.43 | — | — | 0% |
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Medtronic (MDT) Q1 2027 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 2 analysts.
- Low
- $80.00
- Consensus
- $95.80
- Median
- $91.00
- High
- $119.00
- Current
- $81.89
- Upside
- +17.0%
Upside calculated vs most recent trading price of $81.89.
Analyst ratings
Consensus: Buy — based on 51 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 10, 2026 | TD Cowen | maintain | Buy | Buy |
| Jul 6, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Jun 17, 2026 | Needham | maintain | Buy | Buy |
| Jun 5, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Jun 5, 2026 | Bernstein | maintain | Outperform | Outperform |
| Jun 4, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Jun 4, 2026 | UBS | maintain | Neutral | Neutral |
| Jun 4, 2026 | TD Cowen | maintain | Buy | Buy |
| Jun 4, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Jun 4, 2026 | Leerink Partners | maintain | Outperform | Outperform |
- Jul 10, 2026TD CowenBuy
- Jul 6, 2026Evercore ISI GroupOutperform
- Jun 17, 2026NeedhamBuy
- Jun 5, 2026Goldman SachsNeutral
- Jun 5, 2026BernsteinOutperform
- Jun 4, 2026Wells FargoOverweight
- Jun 4, 2026UBSNeutral
- Jun 4, 2026TD CowenBuy
- Jun 4, 2026RBC CapitalOutperform
- Jun 4, 2026Leerink PartnersOutperform
Frequently asked questions
Medtronic (MDT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.97% TTM
- Dividend Profile3.48% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History7 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.